Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 295 participants.

Also called NCT02657707

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 295 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02657707
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02657707. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04-21 (actual); primary completion 2022-04-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Condition
Carotid Artery Stenosis
Intervention (Device)
Roadsaver™ Carotid Artery Stent Device
Intervention (Device)
Nanoparasol® Embolic Protection System
Lead sponsor
Microvention-Terumo, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02657707
Content hash
38eac897f9e42d46d74fd32fb0917df226e09b7789030513ffa72bdcbd2911d8